Development Level

Tbio 1 | 10,625
Tclin 1 | 602

IMPC Term

abnormal behavior 1 | 226
decreased circulating fructosa... 1 | 31
decreased circulating serum al... 1 | 79
decreased hemoglobin content 1 | 53
decreased pulmonary respirator... 1 | 4
hyperactivity 1 | 108
immune system phenotype 1 | 17
increased circulating alanine ... 1 | 11
increased grip strength 1 | 83
straub tail 1 | 26

Disease

Cancer 2 | 2,346
malignant mesothelioma 2 | 3,162
ovarian cancer 2 | 8,484
tuberculosis 2 | 1,557
22q11 Deletion Syndrome 1 | 7
22q11 partial monosomy syndrome 1 | 6
Agoraphobia 1 | 16
Alcohol dependence 1 | 107
Alcoholic Intoxication, Chronic 1 | 41
Alzheimer's disease 1 | 644
Amphetamine-Related Disorders 1 | 74
Animal Mammary Neoplasms 1 | 136
Anxiety disorder 1 | 22
Attention deficit hyperactivity disorder 1 | 156
Autistic Disorder 1 | 320
Biliary dyskinesia 1 | 7
Bipolar Disorder 1 | 266
CONOTRUNCAL ANOMALY FACE SYNDROME 1 | 6
Calculus in biliary tract 1 | 2
Cerebrovascular disease 1 | 231
Cocaine-Related Disorders 1 | 88
Cognition Disorders 1 | 23
Conduct disorder 1 | 25
Dementia 1 | 129
DiGeorge syndrome 1 | 46
Eating disorder 1 | 24
End Stage Liver Disease 1 | 4
Fetal Growth Retardation 1 | 9
Fibromyalgia 1 | 22
Gilles de la Tourette syndrome 1 | 47
HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO 1 | 3
Hepatic encephalopathy 1 | 25
Heroin dependence 1 | 30
Hypertension 1 | 287
Liver carcinoma 1 | 217
Major Depressive Disorder 1 | 106
Mammary Neoplasms 1 | 410
Mental disorders 1 | 11
Multiple Sclerosis 1 | 498
Neonatal abstinence syndrome 1 | 9
Nicotine dependence 1 | 53
Pain 1 | 70
Pain agnosia 1 | 99
Panic disorder 1 | 55
Parkinson's disease 1 | 364
Peripheral Neuropathy 1 | 303
Personality disorder 1 | 25
Pheochromocytoma 1 | 22
Pontocerebellar hypoplasia 1 | 29
Prostatic Neoplasms 1 | 471
Schizoaffective disorder 1 | 33
Schizophrenia 1 | 501
Shprintzen syndrome 1 | 6
Specific phobia 1 | 7
Substance abuse 1 | 55
Toxic encephalopathy 1 | 131
Velocardiofacial syndrome 1 | 45
Waldenstrons macroglobulinemia 1 | 765
astrocytoma 1 | 1,493
atypical teratoid / rhabdoid tumor 1 | 4,369
ependymoma 1 | 2,514
glioblastoma 1 | 5,572
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
obsessive-compulsive disorder 1 | 34
osteosarcoma 1 | 7,933
pancreatic cancer 1 | 2,300
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
post-traumatic stress disorder 1 | 45
posterior fossa group A ependymoma 1 | 1,511
psoriasis 1 | 6,685
sonic hedgehog group medulloblastoma 1 | 1,482
subependymal giant cell astrocytoma 1 | 2,287

Tissue

Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Endocrine System 2 | 18,512
Female tissues 2 | 18,647
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Nervous System 2 | 18,561
Respiratory system 2 | 17,484
Urinary Tract 2 | 18,444
Skin and soft tissues 1 | 18,115

Target Family

Enzyme 1 | 4,146
Non-IDG 1 | 11,971

Grant Application

5U01DK082345-05 2 | 2
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
Catechol O-methyltransferase COMT Tclin Enzyme -3.43022 2841.1 409